Bispecific Antibodies for the Treatment of Multiple Myeloma

被引：0
|
作者：
Scott R. Goldsmith
Shawn Streeter
Fahrettin Covut
机构：
[1] Judy and Bernard Briskin Center for Multiple Myeloma Research,Division of Oncology
[2] City of Hope Comprehensive Cancer Center,undefined
[3] Washington University School of Medicine,undefined
来源：
Current Hematologic Malignancy Reports | 2022年 / 17卷
关键词：
Bispecific antibodies; Bispecific T-cell engagers; Multiple myeloma; Immunotherapy; BCMA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：286 / 297
页数：11
相关论文
共 50 条
  • [1] Bispecific Antibodies in the Treatment of Multiple Myeloma
    Zhou, Xiang
    Xiao, Xianghui
    Kortuem, Klaus Martin
    Einsele, Hermann
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 361 - 381
  • [2] Bispecific Antibodies for the Treatment of Multiple Myeloma
    Goldsmith, Scott R.
    Streeter, Shawn
    Covut, Fahrettin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (06) : 286 - 297
  • [3] Bispecific antibodies in the treatment of multiple myeloma
    Devasia, Anup Joseph
    Chari, Ajai
    Lancman, Guido
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [4] Bispecific antibodies in multiple myeloma
    Escure, Guillaume
    Manier, Salomon
    BULLETIN DU CANCER, 2021, 108 (10) : S205 - S212
  • [5] Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
    Zhou, Xiang
    Einsele, Hermann
    Danhof, Sophia
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [6] Bispecific antibodies in multiple myeloma treatment: A journey in progress
    Cho, Shih-Feng
    Yeh, Tsung-Jang
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Bispecific Antibodies in Multiple Myeloma: Present and Future
    Lancman, Guido
    Sastow, Dahniel L.
    Cho, Hearn J.
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir S.
    Richard, Shambavi
    Richter, Joshua
    Sanchez, Larysa
    Chari, Ajai
    BLOOD CANCER DISCOVERY, 2021, 2 (05): : 423 - 433
  • [8] Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives
    Parrondo, Ricardo D.
    Ailawadhi, Sikander
    Cerchione, Claudio
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma
    Ludwig, Heinz
    Munshi, Nikhil C.
    Terpos, Evangelos
    Schweitzer, Ilvy
    Raje, Noopur
    Moreau, Philippe
    Nooka, Ajay
    BLOOD ADVANCES, 2024, 8 (18) : 4979 - 4982
  • [10] CMV Reactivation During Treatment with Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma
    Jurgens, Eric
    Shekarkhand, Tala
    Rueda, Colin
    Nemirovsky, David
    Derkach, Andriy
    Firestone, Ross
    Miller, Kevin
    Costa, Bruno
    Rajeeve, Sridevi
    Lesokhin, Alexander
    Korde, Neha
    Tan, Carlyn
    Hashmi, Hamza
    Hassoun, Hani
    Maclachlan, Kylee
    Shah, Urvi
    Hultcrantz, Malin
    Hamadeh, Issam
    Giralt, Sergio
    Chung, David
    Landau, Heather
    Scordo, Michael
    Usmani, Saad
    Mailankody, Sham
    Shahid, Zainab
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S63 - S64
12345